Teva Lawsuit Labels The IRA A ‘Fiction’ As Austedo Opens Up To Price Negotiations
Pricing Scheme ‘Hurts Generics And Biosimilars, Weakens Whole Healthcare System’
Teva has filed a complaint in Washington D.C. challenging certain aspects of the drug-pricing provisions of the Inflation Reduction Act as well as Centers for Medicare & Medicaid Services guidance, claiming that the statute will disrupt the balance of innovation and affordability.
